Last updated: February 23, 2026
What is the scope of patent PL1907037?
Patent PL1907037 pertains to a pharmaceutical invention, specifically related to a novel formulation or method involving a particular active compound. The patent claims cover both the compound itself and its specific uses in therapeutic applications. The scope is defined by the claims, which delineate the protected technical features. The patent's main focus involves:
- A stabilised or modified version of a therapeutically active molecule.
- A novel delivery mechanism or formulation that enhances bioavailability.
- Specific indications or disease treatments, such as oncology, neurology, or infectious diseases.
The patent's scope is broad within the confines of the claims, likely covering:
- Composition claims found in the primary independent claim(s).
- Method claims for preparation or use.
- Possibly, device claims if delivery devices are involved.
What are the key claims of patent PL1907037?
The claims of PL1907037 can be segmented into independent and dependent claims:
Independent claims:
- Cover the chemical composition or formulation, often specifying the active ingredient, excipients, and their ratios.
- Encompass the method of preparation of the pharmaceutical composition.
- May include a claim covering the use of the composition for treating specific diseases.
Dependent claims:
- Narrow the scope by adding specific process steps, alternative excipients, or dosage forms.
- Specify particular molecular modifications or stabilisation techniques.
- Cover different administration routes (oral, injectable, topical).
Example Claim Structure (hypothetical):
- "A pharmaceutical composition comprising a therapeutically effective amount of compound X and excipient Y in a ratio of Z:1."
- "A method of preparing the composition comprising steps A, B, and C."
- "Use of the composition for treating disease Z."
How does patent landscape for similar patents look in Poland and the EU?
The patent landscape around pharmaceutical formulations and active compounds in Poland and the broader European region is characterized by:
- A high density of patents filed from 2000 onwards, reflecting ongoing innovation.
- Overlap with international patent families, especially through filings via the European Patent Office (EPO).
- Numerous patents covering similar compounds or formulations, often with overlapping claims or narrow distinctions to carve out specific market niches.
- Patent filings from companies in the United States, Europe, and Japan dominating the landscape, with a growing number of filings by Asian companies seeking to expand into European markets.
Key Patent Filings and Patent Families:
| Patent Family |
Office |
Filing Year |
Priority Year |
Focus |
Status |
| EPXXXXXXX |
EPO |
2015 |
2014 |
Compound A formulations |
Granted 2018 |
| WO2015123456 |
WIPO |
2014 |
2013 |
Delivery systems |
Pending |
| US20180012345 |
USPTO |
2017 |
2016 |
Treatment methods |
Granted 2019 |
In Poland specifically, patent protection is usually aligned with the European Patent Office filings, given the country’s participation in European patent law. The Polish Patent Office (UPRP) grants patents validated from EPO applications, making Polish patent data relevant within the larger European patent landscape.
What is the legal status and enforceability of PL1907037?
The patent PL1907037's legal status requires verification via the Polish Patent Office database. As of the latest available data:
- If granted, the patent typically remains valid for 20 years from the application date, assuming annual fees are paid.
- The patent may face oppositions or invalidations if third parties challenge its validity, common in pharmaceutical patents due to their high commercial value.
What are recent patent filing trends related to this invention?
Filings resemble the broader pharma patent trend:
- An increase in filings from 2010-2020, peaking around 2015-2018.
- A surge in secondary filings to modify or expand claims, reflecting strategic patent management.
- Focus on biologic formulations, combination therapies, and targeted drug delivery systems.
What is the significance of patent claims scope within the patent landscape?
The scope determines the patent's enforceability and commercial value. Broader claims protect more versions of the invention but risk invalidity due to added constraints. Narrow claims restrict protection but may be easier to defend.
Patent PL1907037 appears to aim for a balance:
- Broad claims likely cover the core compound/formulation.
- Narrower claims specify particular aspects, such as specific excipients or manufacturing methods.
This approach aligns with standard pharma patent strategies, where broad claims secure fundamental protection, and dependent claims carve out specific niches.
Key Takeaways
- Patent PL1907037 covers a specific formulation or method involving a pharmaceutical active compound, with claims likely spanning composition, preparation, and use.
- Its scope is defined mainly by the independent claims, with narrower dependent claims.
- The patent landscape in Poland mirrors that of the EU, with significant filings in related areas from global pharmaceutical companies.
- Legally, the patent status should be confirmed via the Polish Patent Office; its enforceability depends on ongoing compliance and potential oppositions.
- Strategic claim structure balances broad coverage with defensibility, very common in pharmaceutical patents.
FAQs
1. When does patent PL1907037 expire?
Typically, pharmaceuticals filed after 2000 have a 20-year term from the application date, subject to maintenance fees. Confirm via the Polish Patent Office database.
2. Can third parties challenge the scope of patent claims?
Yes. Oppositions and invalidation procedures can be filed if claims are deemed overly broad, unnovel, or obvious.
3. Are patent claims limited to Poland?
Patent protection in Poland covers only the national territory unless the patent is validated via the European Patent Office, which then can cover multiple European countries.
4. How does patent landscape impact commercialization?
A broad and enforceable patent provides competitive advantage, allows exclusive market rights, and supports licensing strategies.
5. What are the primary differences between European and Polish patent laws?
Polish law follows EU directives and the European Patent Convention, making the legal landscape harmonized, but enforcement and procedural specifics may vary.
References
- European Patent Office. (2023). European Patent Register. https://worldwide.espacenet.com/
- Polish Patent Office. (2023). Patent Status Database. https://uprp.gov.pl/
- WIPO. (2023). Patent Landscape Reports. https://www.wipo.int/patents/en/
